Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
LA

WKN: A3EMMH | ISIN: KYG5340S1093 | Ticker: 4U4
Frankfurt
18.11.26 | 15:25
0,720 Euro
-5,26 % -0,040
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
LAEKNA INC Chart 1 Jahr
5-Tage-Chart
LAEKNA INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,7200,73018.11.

Aktuelle News zur LAEKNA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.11.LAEKNA-B Completes Phase I SAD Study of LAE103 in Overweight or Obese Subjects2
09.11.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT SUCCESSFUL COMPLETION OF PHASE I SAD STUDY OF LAE103 IN OVERWEIGHT OR OBESE PARTICIPANTS1
13.10.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT UPDATES ON THE 24-WEEK MONOTHERAPY STUDY OF LAE102 SHOWED PROMISING WEIGHT LOSSES FAVORABLE CHANGES IN BODY COMPOSITION ...1
18.09.LAEKNA-B (02105): INTERIM REPORT 20262
08.09.LAEKNA-B (02105): NEXT DAY DISCLOSURE RETURN1
01.09.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT FIRST SUBJECT ENROLLED IN THE PHASE I CLINICAL STUDY OF LAE118 (A NOVEL PI3K ALPHA PAN-MUTANT SELECTIVE INHIBITOR)3
25.08.LAEKNA-B (02105): INTERIM RESULTS ANNOUNCEMENT FOR SIX MONTHS ENDED JUNE 30, 2026-
LAEKNA Aktie jetzt für 0€ handeln
17.08.LAEKNA-B (02105): POSITIVE PROFIT ALERT1
12.08.Laekna's breast cancer drug application accepted in China1
12.08.Laekna: New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration302SHANGHAI, Aug. 11, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center...
► Artikel lesen
12.08.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR LAE002 (AFURESERTIB) WAS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION1
07.08.LAEKNA-B (02105): DATE OF BOARD MEETING3
09.07.LAEKNA-B (02105): NEXT DAY DISCLOSURE RETURN-
02.07.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASES UNDER THE REPURCHASE MANDATE AND PROPOSED SHARE PURCHASE BY SENIOR MANAGEMENT3
29.06.LAEKNA-B (02105): UPDATE ON QUALIFICATION OF COMPANY SECRETARY; RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE-
10.06.LAEKNA-B (02105): VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH VASQUE BIO FOR LAE118 (A NOVEL PI3K ALPHA PAN-MUTANT SELECTIVE INHIBITOR) IN ...2
05.06.LAEKNA-B (02105): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 20261
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1